194 related articles for article (PubMed ID: 20926575)
1. Excessive RNA splicing and inhibition of HIV-1 replication induced by modified U1 small nuclear RNAs.
Mandal D; Feng Z; Stoltzfus CM
J Virol; 2010 Dec; 84(24):12790-800. PubMed ID: 20926575
[TBL] [Abstract][Full Text] [Related]
2. Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.
Exline CM; Feng Z; Stoltzfus CM
J Virol; 2008 Apr; 82(8):3921-31. PubMed ID: 18272582
[TBL] [Abstract][Full Text] [Related]
3. A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.
Madsen JM; Stoltzfus CM
Retrovirology; 2006 Feb; 3():10. PubMed ID: 16457729
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 splicing at the major splice donor site is controlled by highly conserved RNA sequence and structural elements.
Mueller N; Klaver B; Berkhout B; Das AT
J Gen Virol; 2015 Nov; 96(11):3389-3395. PubMed ID: 26385834
[TBL] [Abstract][Full Text] [Related]
5. A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability.
Lützelberger M; Reinert LS; Das AT; Berkhout B; Kjems J
J Biol Chem; 2006 Jul; 281(27):18644-51. PubMed ID: 16675444
[TBL] [Abstract][Full Text] [Related]
6. Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication.
Stoltzfus CM
Adv Virus Res; 2009; 74():1-40. PubMed ID: 19698894
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G.
Mandal D; Exline CM; Feng Z; Stoltzfus CM
J Virol; 2009 Jun; 83(12):6067-78. PubMed ID: 19357165
[TBL] [Abstract][Full Text] [Related]
8. The HIV 5' Gag Region Displays a Specific Nucleotide Bias Regulating Viral Splicing and Infectivity.
Grewe B; Vogt C; Horstkötter T; Tippler B; Xiao H; Müller B; Überla K; Wagner R; Asbach B; Bohne J
Viruses; 2021 May; 13(6):. PubMed ID: 34071819
[TBL] [Abstract][Full Text] [Related]
9. Dynamic nanopore long-read sequencing analysis of HIV-1 splicing events during the early steps of infection.
Nguyen Quang N; Goudey S; Ségéral E; Mohammad A; Lemoine S; Blugeon C; Versapuech M; Paillart JC; Berlioz-Torrent C; Emiliani S; Gallois-Montbrun S
Retrovirology; 2020 Aug; 17(1):25. PubMed ID: 32807178
[TBL] [Abstract][Full Text] [Related]
10. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
Amendt BA; Hesslein D; Chang LJ; Stoltzfus CM
Mol Cell Biol; 1994 Jun; 14(6):3960-70. PubMed ID: 8196635
[TBL] [Abstract][Full Text] [Related]
11. The HIV-1 Tat Protein Enhances Splicing at the Major Splice Donor Site.
Mueller N; Pasternak AO; Klaver B; Cornelissen M; Berkhout B; Das AT
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743356
[TBL] [Abstract][Full Text] [Related]
12. HIV-1: To Splice or Not to Splice, That Is the Question.
Emery A; Swanstrom R
Viruses; 2021 Jan; 13(2):. PubMed ID: 33530363
[TBL] [Abstract][Full Text] [Related]
13. Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.
Tranell A; Fenyö EM; Schwartz S
J Biol Chem; 2010 Oct; 285(41):31537-47. PubMed ID: 20685659
[TBL] [Abstract][Full Text] [Related]
14. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
Schwartz S; Felber BK; Pavlakis GN
J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
[TBL] [Abstract][Full Text] [Related]
15. Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.
Erkelenz S; Poschmann G; Theiss S; Stefanski A; Hillebrand F; Otte M; Stühler K; Schaal H
J Virol; 2013 Mar; 87(5):2721-34. PubMed ID: 23255807
[TBL] [Abstract][Full Text] [Related]
16. Behind the scenes of HIV-1 replication: Alternative splicing as the dependency factor on the quiet.
Sertznig H; Hillebrand F; Erkelenz S; Schaal H; Widera M
Virology; 2018 Mar; 516():176-188. PubMed ID: 29407375
[TBL] [Abstract][Full Text] [Related]
17. An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication.
Madsen JM; Stoltzfus CM
J Virol; 2005 Aug; 79(16):10478-86. PubMed ID: 16051840
[TBL] [Abstract][Full Text] [Related]
18. Use of modified U1 snRNAs to inhibit HIV-1 replication.
Sajic R; Lee K; Asai K; Sakac D; Branch DR; Upton C; Cochrane A
Nucleic Acids Res; 2007; 35(1):247-55. PubMed ID: 17158512
[TBL] [Abstract][Full Text] [Related]
19. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
Wentz MP; Moore BE; Cloyd MW; Berget SM; Donehower LA
J Virol; 1997 Nov; 71(11):8542-51. PubMed ID: 9343212
[TBL] [Abstract][Full Text] [Related]
20. Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing.
Stoltzfus CM; Madsen JM
Curr HIV Res; 2006 Jan; 4(1):43-55. PubMed ID: 16454710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
